ULTRAGENYX PHARMACEUTICAL INC. Operating Leases, Future Minimum Payments, Due Thereafter
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Operating Leases, Future Minimum Payments, Due Thereafter of $8.45 million as of 2018-12-31, per its 10-K filed 2019-02-20.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter · last filed 2019-02-20
- 2018-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $8.45M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $9.03M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $11.45M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $13.79M.
| Period end | Operating Leases, Future Minimum Payments, Due Thereafter |
|---|---|
| 2018-12-31 | $8.45M 10-K · filed 2019-02-20 |
| 2017-12-31 | $9.03M 10-K · filed 2018-02-21 |
| 2016-12-31 | $11.45M 10-K · filed 2017-02-17 |
| 2015-12-31 | $13.79M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |